PO Scope of Work_ITB 2526 074.pdf

ATTACHMENT A

PURCHASE ORDER SCOPE OF WORK

PMT-57 1 v.25.1

1. Description of Service The Provider must provide the services described within this Scope of Work (Scope).

1.1 The Provider shall coordinate with Florida municipalities to facilitate the collection and transfer of Wastewater Samples for drug analysis. The Provider shall calibrate wastewater testing equipment and analytical methods in accordance with the Department of Children and Families’ approved list of substances outlined in 5.3.3.1. The Provider must demonstrate expertise in wastewater-based epidemiology and possess a fully equipped laboratory capable of performing liquid chromatography-tandem mass spectrometry (LC-MS/MS) for comprehensive drug detection.

2. Governance Based on §287.057(19), Florida Statutes (F.S.), if applicable, Provider(s) under this contract will be prohibited from participating in any other engagement in which the Provider provides related content as this would create a conflict of interest. The Provider shall comply with all applicable state and federal requirements, including, without limitation:

3. Term

3.1 The anticipated term of the resulting Contract is 3/30/2026, through 6/30/2028. The term of the resulting Contract is subject to change based on the actual execution date of the resulting Contract.

3.2 In accordance with §287.058(1)(g), F.S., the Contract resulting from this procurement may be renewed for a period that may not exceed three years or the term of the resulting original Contract period, whichever is longer. Renewal of the Contract shall be in writing and subject to the same terms and conditions set forth in the original Contract. A renewal may not include any compensation for costs associated with the renewal. Renewals are contingent upon satisfactory performance as determined by the Department, are subject to the availability of funds, and optional to the Department.

3.3 The total term (original term and renewal term) of the resulting Contract will be limited to the term authorized by the applicable procurement or contract vehicle, unless the Provider’s contract includes duration or survivability language that permits the Department to contract with the Provider past expiration.

3.4 Funding under this Contract is subject to the availability of funds. The Department reserves the right to expand the Scope performed by the Provider should additional needs and funding become available. Additional services may be included in, or added to, any purchase order(s), upon mutual written agreement, and through issuance of a change order.

4. Composition of the Contract

4.1 This Contract is composed of the documents listed in this section. In the event of any conflict between the documents, the documents shall be interpreted in the following order of precedence:

4.1.1 Purchase Order Scope of Work (PMT-57), and other attached documents: All other attachments and exhibits to the Contract referenced in the solicitation shall also be part of the resulting Contract, if any.

4.1.2 The Department’s Purchase Order Terms and Conditions, located at:

https://www.myflfamilies.com/general-information/contracted-client-services/library.

4.1.3 Department of Children and Families Standard Contract Definitions, located at:

https://www.myflfamilies.com/general-information/contracted-client-services/library.

4.1.4 PUR 1000 Form, located at:

https://www.dms.myflorida.com/business_operations/state_purchasing/state_agency_resources/state_ purchasing_pur_forms.

https://www.myflfamilies.com/general-information/contracted-client-services/library https://www.myflfamilies.com/general-information/contracted-client-services/library https://www.dms.myflorida.com/business_operations/state_purchasing/state_agency_resources/state_purchasing_pur_forms https://www.dms.myflorida.com/business_operations/state_purchasing/state_agency_resources/state_purchasing_pur_forms

PMT-57 2 v.25.1

4.1.5 Provider Response: The Provider’s Response and any additional submittals, if incorporated into or attached to the Contract.

4.2 Notwithstanding the order of precedence indicated, for purchases based on a State Term Contract (STC) or an enterprise Alternative Contract Source (ACS) procured for state agency use by the Department of Management Services (DMS), the terms of the underlying STC or DMS enterprise ACS agreement shall prevail over conflicting terms in other documents in the order of precedence, unless by the terms of that underlying STC or ACS agreement the “Customer” is explicitly authorized to vary the terms to the State’s detriment.

5. Elements of Services The Provider is responsible for meeting all requirements set forth in this Scope.

5.1 Service Delivery

5.1.1 Service Delivery Location

The work under this agreement shall be performed at location(s) determined by the Provider, provided all services meet the requirements of this Scope of Work and applicable laws.

The Provider is responsible for any incremental costs associated with having staff work remotely.

5.2 Equipment

5.2.1 The Provider must provide all equipment required for services within this Scope.

5.3 Task List

The Provider will perform the following Implementation Tasks:

5.3.1 The Provider will contact and coordinate with at least six (6) of the Florida municipalities listed below in 5.3.1.1, unless otherwise directed in writing by the Department to orchestrate the weekly transfer of Wastewater Samples. For Regular Sampling the Provider shall coordinate transfers from up to three (3) different treatment facilities within each Municipality for a total of 18 weekly samples (three

(3) facilities across six (6) municipalities). For Extensive Sampling, the Provider shall coordinate transfers from Two (2) municipalities, with a minimum of two (2) treatment facilities per municipality, and each facility shall transfer four (4) samples per week to a laboratory or facility designated by the Provider for analysis (see 5.3.4 for details) for a minimum total of 16 samples per week (two municipalities x two (2) facilities x four (4) samples). Regular and Extensive Sampling shall be performed concurrently as part of the base Scope of Work.

Coordination activities include identifying participating wastewater treatment facilities, facilitating sample collection logistics, and supporting the execution of any required agreements necessary for Sample Transfer. This task must be completed and made available to the Department no later than June 30, 2026.

5.3.1.1 Florida Municipalities:

5.3.1.1.1 Tampa/St. Petersburg,

5.3.1.1.2 Gainesville,

5.3.1.1.3 Miami/Ft. Lauderdale,

5.3.1.1.4 Orlando,

5.3.1.1.5 Tallahassee,

5.3.1.1.6 Pensacola, PMT-57 3 v.25.1

5.3.1.1.7 Jupiter/Palm Beach,

5.3.1.1.8 Jacksonville.

5.3.2 The Provider shall design, develop, implement, and host a secure data visualization dashboard (Dashboard) that allows the Department to view wastewater Drug Surveillance Results. At minimum Dashboard data updates should occur weekly. The Dashboard must be completed and available to the Department by no later than June 30, 2026.

5.3.2.1 See Exhibit A for Minimum Dashboard Requirements.

5.3.2.2 The Dashboard shall be accessible for up to ten (10) DCF employees.

5.3.2.3 The Dashboard shall be password protected.

5.3.2.4 The Dashboard shall be capable of displaying trend data in a clear and user-friendly format.

5.3.2.5 The Dashboard data should include the amount of each substance in the water as an average consumption rate and should specify substances by location and timeframe.

5.3.2.6 Dashboard data analysis functionality should include trends represented by graphs, prevalence, and emerging drug threats. Department employees with access to the Dashboard must have the ability to filter and export data and graphs. These exports should be available in either text or excel.

5.3.2.7 The Dashboard shall be hosted in a secure environment located within the United States. The Provider shall implement administrative, technical, and physical safeguards to protect Dashboard data against unauthorized access, disclosure, alteration, or destruction. At a minimum, the Dashboard shall utilize encrypted transmission protocols (HTTPS/TLS) and encrypted data storage.

Access to the Dashboard shall be role-based and limited to authorized Department personnel. The Provider shall notify the Department in writing within seventy-two (72) hours of discovering any actual or suspected security incident involving Dashboard data and shall cooperate with the Department in any required investigation or remediation efforts.

5.3.2.8 The Provider shall ensure that the Dashboard is available for Department access at least ninety-nine percent (99%) of the time, excluding scheduled maintenance. Scheduled maintenance shall be communicated to the Department in advance and performed outside of normal business hours whenever practicable.

In the event of an unplanned outage, the Provider shall promptly notify the Department and provide status updates until service is restored.

5.3.3 The Provider shall calibrate wastewater testing equipment and validate analytical methods to align with at least the 20 substances, identified by an asterisk (*) on the Department’s approved list of substances as specified in 5.3.3.1. The Department shall monitor and maintain this list and may update it at its discretion. The Department shall provide written notice to the Provider of any changes to the approved list. The Provider shall have up to forty-five (45) business days from receipt of written notice to add or remove substances and re-calibrate testing equipment and analytical methods to align with the requested changes at no additional cost to the Department provided that such changes do not exceed five (5) substance modifications per Contract year. Modifications exceeding this threshold, or requiring material method redevelopment beyond standard calibration adjustments, shall require a mutually executed written change order. This initial calibration and validation required in this section shall be completed and made available to the Department no later than June 30, 2026.

PMT-57 4 v.25.1

5.3.3.1 DCF Approved List of Substances:

SUBSTANCE CATEGORY SUBSTANCE NAME

Opioids & Metabolites: 1. 6-acetylmorphine (Heroin Metabolite) *

2. Buprenorphine *

3. Carfentanil

4. EDDP (Methadone metabolite) *

5. Fentanyl *

6. Hydrocodone *

7. Methadone *

8. Norbuprenorphine (Buprenorphine metabolite)

9. Norfentanyl (Fentanyl metabolite)

10. Codeine *

11. Oxycodone *

12. Mitagynine (Kratom) *

13. Desomorphine *

14. Etonitazene *

15. Metodesnitazene *

16. Gabapentin *

Stimulants & Metabolites: 17. 4-hydroxymethamphetamine (Methamphetamine metabolite)

18. Amphetamine *

19. Cocaine *

20. Methamphetamine *

Emerging Drugs: 21. 4-hydroxyxylazine (Xylazine metabolite) *

22. Isotonitazene *

23. Para-Fluorofentanyl *

24. Xylazine *

Other Substances: 25. Alprazolam

26. Caffeine

27. Etizolam

28. Etomidate

29. Ketamine

30. Medetomidine

31. Mescaline

32. N,N-Dimethyltryptamine

33. Naloxone

34. Nicotine

35. Norketamine (Ketamine metabolite)

Re-Occurring Tasks:

5.3.4 The Provider shall collect or receive Wastewater Samples from Participating Municipalities referenced in 5.3.1. This Task should initially begin within thirty (30) calendar days of Purchase Order Execution and re-occur weekly thereafter.

5.3.4.1 Regular Sampling – Provider shall collect or receive samples from three (3) different treatment facilities within six (6) municipalities for a minimum of eighteen (18) samples per week. (6 Municipalities x 3 sites = 18 samples per week)

PMT-57 5 v.25.1

5.3.4.2 Extensive Sampling - Provider shall collect or receive samples from two (2) different treatment facilities within two (2) Municipalities for a minimum of four (4) sites total.

Provider shall collect samples four (4) times per week at each site (Monday, Wednesday, Friday, Saturday). A minimum of sixteen (16) samples per week (4 sites x 4 samples per week = 16 samples per week)

5.3.4.3 The fixed price established under this Contract includes performance of both Regular Sampling and Extensive Sampling concurrently, for a combined maximum of thirty-four

(34) samples per week (eighteen (18) Regular Sampling samples and sixteen (16) Extensive Sampling samples). Sampling volumes exceeding thirty-four (34) samples per week shall require a mutually executed written change order.

5.3.5 The Provider shall analyze Wastewater Samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and a Thermo Scientific Vanquish UHPLC coupled to an Altis Plus triple quadrupole mass spectrometer or an equivalent device capable of analyzing the presence of drugs in wastewater. At minimum the Provider must provide analysis result data within 14 calendar days from receipt of the sample. This Task should initially begin within forty-five (45) calendar days of Purchase Order Execution and re-occur weekly thereafter.

5.3.6 The Provider shall re-calibrate testing equipment and analytical methods to align with the requested changes to the DCF Approved List of Substances in 5.3.3.1. This Task shall be performed at the Department’s discretion, and the Provider will have up to forty-five (45) business days from date of request to complete the re-Calibration subject to the annual modification limitation described in 5.3.3.

5.3.7 The Provider shall continue to host and maintain the Dashboard and import water sample results, entering Dashboard Updates weekly to reflect newly analyzed data. The Provider will have seven (7) calendar days from the completion of the Dashboard to have the initial data imported and available to the Department no later than July 7, 2026, and re-occur weekly thereafter.

5.4 Reports

The Provider will submit the following reports in the time and manner specified in 7.1

5.4.1 Monthly Status Update should include at minimum:

5.4.1.1 Overall project status summary for the reporting period.

5.4.1.2 Summary of activities completed for the reporting period.

5.4.1.3 Description of planned activities for the next reporting period.

5.4.1.4 Identification of issues, risks, and barriers.

5.4.1.5 Updated schedule and milestone status.

5.5 Provider Requirements

5.5.1 Laboratory certifications for liquid chromatography-tandem mass spectrometry (LC-MS/MS) and compliance with state and federal standards.

5.5.2 Have a Thermo Scientific Vanquish UHPLC coupled to an Altis Plus triple quadrupole mass spectrometer or an equivalent device capable of analyzing the presence of drugs in wastewater.

5.5.3 Affiliation with the National Drug Early Warning System (NDEWS).

5.5.4 Ability to collect data from any region in Florida, not limited to pre-defined areas identified in

5.3.1.

5.5.5 Expertise in data analysis and interpretation for public health and policy use.

6. Deliverables, Minimum Performance Measures, and Financial Consequences

PMT-57 6 v.25.1

6.1 The Provider must complete or submit the following deliverables in the time and manner specified herein.

6.2 Pursuant to §287.058, F.S., the Contract must contain financial consequences that will apply if the Provider fails to perform in accordance with the Contract terms.

6.3 The deliverables must meet the following minimum service level, and failure of the Provider to complete or submit a deliverable in the time and manner specified will result in a reduction of payment for that deliverable:

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

PMT-57 7 v.25.1

DELIVERABLES, MINIMUM PERFORMANCE MEASURES, AND FINANCIAL CONSEQUENCES

Deliverable # and Description

Minimum Performance Measure

Supporting Documentation Qualitative Monitoring Criteria

Financial Consequence Amount

Deliverable 1:

Affiliated with six (6) Florida Municipalities in accordance with Task 5.3.1.

100% completion of task 5.3.1.

Copies of agreements with Participating Municipalities.

Monthly Status Update Failure to complete or submit Deliverable 1 in the time and manner specified will result in a payment reduction equal to ten percent (10%) of the invoiced amount for this deliverable.

Deliverable 2:

Dashboard in accordance with Task 5.3.2.

100% completion of task 5.3.2.

Department access to and visual confirmation of the Dashboard.

Monthly Status Update & Dashboard functionality, usability, and accessibility.

Failure to complete or submit Deliverable 2 in the time and manner specified will result in a payment reduction equal to ten percent (10%) of the invoiced amount for this deliverable.

Deliverable 3 Testing Calibration in accordance with Task 5.3.3.

100% completion of task 5.3.3.

Written confirmation or e-mail attestation that Calibration has been completed

Monthly Status Update & Calibration supports accurate and reliable analysis of Wastewater Samples.

Failure to complete or submit Deliverable 3 in the time and manner specified will result in a payment reduction equal to ten percent (10%) of the invoiced amount for this deliverable.

Deliverable 4 Wastewater Surveillance Services in accordance with Tasks 5.3.4 through 5.3.7.

100% completion of tasks 5.3.4 through 5.3.7.

Visual confirmation of updated Dashboard data.

Monthly Status Update & Data is current, complete, and updated.

Failure to complete or submit Deliverable 4 in the time and manner specified will result in a payment reduction equal to ten percent (10%) of the total monthly invoiced amount.

PMT-57 8 v.25.1

7. Reports

7.1 The Provider shall adhere to reporting requirements included in this section. The Department reserves the right to direct the Provider to amend or update its reports and/or report formats in accordance with the best interests of the Department and at no cost to the Department. The Department will notify the Provider of such modification, in writing.

REPORTS

# Title Due Date Section Reference

1. Monthly Status Update 15th day of the month following the service month 5.4

7.2 The Department reserves the right to modify reporting formats and submission timetables resulting from changing priorities or management direction.

7.3 Executive Compensation Reporting

7.4 Annually on or before May 1, the Provider shall complete and return the Executive Compensation Annual Report (Form PCMT-08), located at: https://www.myflfamilies.com/general-information/contracted-client-services/library.

7.5 All reports shall be developed and produced at no cost to the Department.

8. Invoicing and Payments

8.1 General Information

8.1.1 A Purchase Order (PO) will be issued to the Provider.

8.1.2 The method of payment for this purchase is fixed price.

8.1.2.1 The fixed price includes all labor, equipment, calibration, analysis, reporting, dashboard hosting, and sampling activities described in 5.3.1 through 5.3.7, including concurrent Regular and Extensive Sampling up to a combined maximum of thirty-four (34) samples per week. Any material expansion of scope, including additional sampling sites, increased sampling frequency beyond the limits stated in 5.3.4.3, or substance list modifications exceeding the limitations in 5.3.3, shall require a mutually executed written change order.

8.1.3 The Provider will not receive payment in advance for goods or services described in this Scope.

8.2 Invoicing

8.2.1 The Provider must submit an invoice upon completion of goods or services that provides a detailed accounting during the invoice period for which payment is being requested. Invoices must be sufficient for a proper pre-audit and post-audit thereof.

8.2.2 The invoice shall be submitted along with documentation supporting completion of each deliverable, milestone, and/or recurring maintenance and operations monthly cost. Each invoice must include the following information:

8.2.2.1 PO number,

8.2.2.2 Provider name and address,

8.2.2.3 Provider federal identification number,

8.2.2.4 Date(s) and services provided, https://www.myflfamilies.com/general-information/contracted-client-services/library https://www.myflfamilies.com/general-information/contracted-client-services/library

PMT-57 9 v.25.1

8.2.2.5 Identification of any deliverable(s) due during the invoicing period, if applicable,

8.2.2.6 Invoice amount,

8.2.2.7 PO balance after payment of invoice, and

8.2.2.8 Signature of Provider’s authorized representative and date signed.

8.2.3 The Department may require any other information from the Provider that the Department deems necessary to verify the completion of services.

8.3 Payments

8.3.1 Frequency of Payment: This will be a combination of One-time Paid Deliverables and Monthly Deliverables to be paid, upon Department acceptance of each deliverable.

8.3.2 The Provider will receive payment for work described in this Scope after proof of completion is submitted to the Department and is deemed to meet the Department’s satisfaction.

8.3.3 Payments to the Provider through this PO will be made through MyFloridaMarketPlace (MFMP), thus it is required that the Provider is registered with MFMP.

8.3.4 MFMP registration instructions are located at:

https://www.dms.myflorida.com/business_operations/state_purchasing/myfloridamarketplace/mfmp_ve ndors/requirements_for_vendor_registration

8.3.5 The PO and this document contain all terms and conditions agreed upon by all parties involved, the terms and conditions shall govern all transactions between the Department and the Provider related to this Contract. This Contract may only be modified or amended upon mutual written agreement of the Department and the Provider. Any modification to this PO will be addressed through a change order within MFMP.

8.3.6 Effective July 1, 2024, the MFMP transaction fees imposed for the use of MFMP are equal to seven-tenths of one percent (0.7%) of the payment issued. More information is located at:

https://www.dms.myflorida.com/business_operations/state_purchasing/myfloridamarketplace/mfmp_ve ndors/transaction_fee_and_reporting.

9. Provider Travel Reimbursement The Provider will not be reimbursed for any travel expenses under this PO.

10. Data Ownership and Intellectual Property

10.1 All data generated, collected, analyzed, or reported under this Contract, including raw analytical results, processed data, reports, and Dashboard content, shall be the property of the Department of Children and Families.

10.2 The Provider shall not publish, disclose, or otherwise use data generated under this Contract for research, academic, or other purposes without the prior written approval of the Department.

10.3 Upon expiration or termination of the Contract, the Provider shall provide the Department with an electronic copy of all data in a mutually agreed-upon, commercially reasonable format.

11. Definitions Program or Service Specific Terms and definitions are:

PROGRAM/SERVICE SPECIFIC TERMS

Term Definition https://www.dms.myflorida.com/business_operations/state_purchasing/myfloridamarketplace/mfmp_vendors/requirements_for_vendor_registration https://www.dms.myflorida.com/business_operations/state_purchasing/myfloridamarketplace/mfmp_vendors/requirements_for_vendor_registration https://www.dms.myflorida.com/business_operations/state_purchasing/myfloridamarketplace/mfmp_vendors/transaction_fee_and_reporting https://www.dms.myflorida.com/business_operations/state_purchasing/myfloridamarketplace/mfmp_vendors/transaction_fee_and_reporting

PMT-57 10 v.25.1

Wastewater Sample A 24-hour composite influent wastewater sample collected from a participating municipal wastewater treatment facility for the purpose of drug surveillance analysis under this Contract.

Participating Municipality

A Florida municipality that has agreed to participate in wastewater sampling and sample transfer activities under this Contract.

Sample Transfer The process of collecting, packaging, and shipping wastewater samples from participating municipalities to the provider’s laboratory for analysis.

Dashboard A secure, password-protected, web-based data visualization platform developed by the Provider that will display wastewater drug surveillance results for Department access.

Dashboard Update The posting of newly analyzed wastewater data to the Dashboard in accordance with the minimum update frequency specified in Task 5.3.4.

Drug Surveillance Results

Analytical results generated from wastewater samples that identify and quantify the presence of selected substances as approved by the Department.

Approved Substance List

The list of drugs and metabolites provided or approved by the Department of Children and Families for analysis under this Contract.

Calibration The process of configuring wastewater testing equipment and analytical methods to accurately detect substances included on the Approved Substance List.

Substance Modification

The addition or removal of a single substance from the Approved Substance List that requires calibration adjustment and validation of analytical methods under this Contract. Each individual substance added or removed shall constitute one (1) Substance Modification for purposes of the annual limitation described in 5.3.3.

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

EXHIBIT A

Minimum Data Dashboard Requirements

PMT-57 11 v.25.1

At a minimum, the Dashboard must clearly show:

1. Sampling Identification

• Sampling location / site ID

• Sample collection date/time

• Sampler or responsible entity

2. Sampling Status & Coverage

• Sampling frequency (e.g., daily, weekly, monthly)

• Missed or late samples clearly flagged

3. Analytical Results

• Identified Contaminants (See DCF Approved Substances List 5.3.3.1.)

• Consumption rate

• Detection limit / reporting limit

4. Data Quality Indicators

• Validated vs. pending vs. rejected results

• Laboratory name and certification status

• QA/QC flags (e.g., holding time exceeded, sample compromised)

5. Trends & Historical Context

• Time-series trends for key parameters

• Ability to filter by location, parameter, or time period

6. Alerts & Action Tracking (Minimum Version)

• Automatic flags for:

o Missed samples o Suspected outliers

• Basic corrective action status (open / in progress / closed)

7. Security & Access

• Compliance with data retention and recordkeeping requirements